Emergence of HCV genotype 6 and its new variants among intravenous drug users in Manipur, a north-eastern state of India

Background: Manipur, a north-eastern state of India, has a high incidence of intravenous drug use with an equally high prevalence of Hepatitis C virus (HCV) infection. Objectives: This cross-sectional study aimed to evaluate the impact of certain risk factors enhancing the susceptibility of acquirin...

Full description

Saved in:
Bibliographic Details
Main Authors: Raina Das, Supradip Dutta, Sagnik Bakshi, Aritra Biswas, Shreyasi Nath, Moumita Majumdar, Priya Verma, Upasana Baskey, Shanta Dutta, Provash Chandra Sadhukhan
Format: Article
Language:English
Published: SAGE Publishing 2025-07-01
Series:Therapeutic Advances in Infectious Disease
Online Access:https://doi.org/10.1177/20499361251351302
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849703549914578944
author Raina Das
Supradip Dutta
Sagnik Bakshi
Aritra Biswas
Shreyasi Nath
Moumita Majumdar
Priya Verma
Upasana Baskey
Shanta Dutta
Provash Chandra Sadhukhan
author_facet Raina Das
Supradip Dutta
Sagnik Bakshi
Aritra Biswas
Shreyasi Nath
Moumita Majumdar
Priya Verma
Upasana Baskey
Shanta Dutta
Provash Chandra Sadhukhan
author_sort Raina Das
collection DOAJ
description Background: Manipur, a north-eastern state of India, has a high incidence of intravenous drug use with an equally high prevalence of Hepatitis C virus (HCV) infection. Objectives: This cross-sectional study aimed to evaluate the impact of certain risk factors enhancing the susceptibility of acquiring HCV. Design: A total of 1008 participants from various risk groups, from nine districts across the state, were enrolled. Blood samples along with demographic data were collected from the study participants. Methods: HCV RNA was isolated and nested RT-PCR was performed followed by Sanger sequencing for genotyping. Phylogenetic and phylogeographic studies were further conducted. Results: Of the total, 493 (48.90%) samples were HCV sero-reactive. Among the sero-reactive samples, 406 (82.35%) were HCV RNA positive. In case of the subgroup PWID + HIV, sero-reactivity (82.22%) and viremia (90.54%) were observed to be exceptionally high. It was noted that HCV sero-reactivity increased four times in people living with HIV (PLHIV) who continued to inject drugs. Three HCV genotypes and eight subtypes were circulating in this study population. Conclusion: In PLHIV who continued to inject drugs, HCV sero-reactivity increased four-fold. About 40% of the population living with HCV belonged to genotype 6, while genotype 1 showed a noticeable decline. Phylogeographic analyses and spatiotemporal reconstructions revealed that most of the subtypes migrated from far south-east Asian countries like Thailand, Malaysia, Myanmar, and Singapore.
format Article
id doaj-art-afb80a8fa0d14bfcbddced214ec433fb
institution DOAJ
issn 2049-937X
language English
publishDate 2025-07-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Infectious Disease
spelling doaj-art-afb80a8fa0d14bfcbddced214ec433fb2025-08-20T03:17:14ZengSAGE PublishingTherapeutic Advances in Infectious Disease2049-937X2025-07-011210.1177/20499361251351302Emergence of HCV genotype 6 and its new variants among intravenous drug users in Manipur, a north-eastern state of IndiaRaina DasSupradip DuttaSagnik BakshiAritra BiswasShreyasi NathMoumita MajumdarPriya VermaUpasana BaskeyShanta DuttaProvash Chandra SadhukhanBackground: Manipur, a north-eastern state of India, has a high incidence of intravenous drug use with an equally high prevalence of Hepatitis C virus (HCV) infection. Objectives: This cross-sectional study aimed to evaluate the impact of certain risk factors enhancing the susceptibility of acquiring HCV. Design: A total of 1008 participants from various risk groups, from nine districts across the state, were enrolled. Blood samples along with demographic data were collected from the study participants. Methods: HCV RNA was isolated and nested RT-PCR was performed followed by Sanger sequencing for genotyping. Phylogenetic and phylogeographic studies were further conducted. Results: Of the total, 493 (48.90%) samples were HCV sero-reactive. Among the sero-reactive samples, 406 (82.35%) were HCV RNA positive. In case of the subgroup PWID + HIV, sero-reactivity (82.22%) and viremia (90.54%) were observed to be exceptionally high. It was noted that HCV sero-reactivity increased four times in people living with HIV (PLHIV) who continued to inject drugs. Three HCV genotypes and eight subtypes were circulating in this study population. Conclusion: In PLHIV who continued to inject drugs, HCV sero-reactivity increased four-fold. About 40% of the population living with HCV belonged to genotype 6, while genotype 1 showed a noticeable decline. Phylogeographic analyses and spatiotemporal reconstructions revealed that most of the subtypes migrated from far south-east Asian countries like Thailand, Malaysia, Myanmar, and Singapore.https://doi.org/10.1177/20499361251351302
spellingShingle Raina Das
Supradip Dutta
Sagnik Bakshi
Aritra Biswas
Shreyasi Nath
Moumita Majumdar
Priya Verma
Upasana Baskey
Shanta Dutta
Provash Chandra Sadhukhan
Emergence of HCV genotype 6 and its new variants among intravenous drug users in Manipur, a north-eastern state of India
Therapeutic Advances in Infectious Disease
title Emergence of HCV genotype 6 and its new variants among intravenous drug users in Manipur, a north-eastern state of India
title_full Emergence of HCV genotype 6 and its new variants among intravenous drug users in Manipur, a north-eastern state of India
title_fullStr Emergence of HCV genotype 6 and its new variants among intravenous drug users in Manipur, a north-eastern state of India
title_full_unstemmed Emergence of HCV genotype 6 and its new variants among intravenous drug users in Manipur, a north-eastern state of India
title_short Emergence of HCV genotype 6 and its new variants among intravenous drug users in Manipur, a north-eastern state of India
title_sort emergence of hcv genotype 6 and its new variants among intravenous drug users in manipur a north eastern state of india
url https://doi.org/10.1177/20499361251351302
work_keys_str_mv AT rainadas emergenceofhcvgenotype6anditsnewvariantsamongintravenousdrugusersinmanipuranortheasternstateofindia
AT supradipdutta emergenceofhcvgenotype6anditsnewvariantsamongintravenousdrugusersinmanipuranortheasternstateofindia
AT sagnikbakshi emergenceofhcvgenotype6anditsnewvariantsamongintravenousdrugusersinmanipuranortheasternstateofindia
AT aritrabiswas emergenceofhcvgenotype6anditsnewvariantsamongintravenousdrugusersinmanipuranortheasternstateofindia
AT shreyasinath emergenceofhcvgenotype6anditsnewvariantsamongintravenousdrugusersinmanipuranortheasternstateofindia
AT moumitamajumdar emergenceofhcvgenotype6anditsnewvariantsamongintravenousdrugusersinmanipuranortheasternstateofindia
AT priyaverma emergenceofhcvgenotype6anditsnewvariantsamongintravenousdrugusersinmanipuranortheasternstateofindia
AT upasanabaskey emergenceofhcvgenotype6anditsnewvariantsamongintravenousdrugusersinmanipuranortheasternstateofindia
AT shantadutta emergenceofhcvgenotype6anditsnewvariantsamongintravenousdrugusersinmanipuranortheasternstateofindia
AT provashchandrasadhukhan emergenceofhcvgenotype6anditsnewvariantsamongintravenousdrugusersinmanipuranortheasternstateofindia